Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol for delirium in mechanically ventilated ICU patients
NCT00300391Phase 3Terminated
- Sponsor
- University of Pittsburgh
- Start
- Mar 2006
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of haloperidol in delirium, sponsored by University of Pittsburgh. Primary endpoints: 28-day All-cause Mortality and 90-day All-cause Mortality. Started Mar 2006; status: terminated.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NCT00300391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300391.